{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:32:49Z","timestamp":1762507969180},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10096-019-03748-z","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T20:04:16Z","timestamp":1576008256000},"page":"483-491","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults"],"prefix":"10.1007","volume":"39","author":[{"given":"Laura","family":"Campogiani","sequence":"first","affiliation":[]},{"given":"Sofia","family":"Tejada","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Ferreira-Coimbra","sequence":"additional","affiliation":[]},{"given":"Marcos I.","family":"Restrepo","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"5","key":"3748_CR1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","volume":"148","author":"MS Niederman","year":"1993","unstructured":"Niederman MS, Bass JB, Campbell GD et al (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical section of the American Lung Association. Am Rev Respir Dis 148(5):1418\u20131426","journal-title":"Am Rev Respir Dis"},{"key":"3748_CR2","doi-asserted-by":"crossref","unstructured":"Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996;153(5):1711\u201325","DOI":"10.1164\/ajrccm.153.5.8630626"},{"issue":"4","key":"3748_CR3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1183\/09031936.98.11040986","volume":"11","author":"ER Society","year":"1998","unstructured":"Society ER (1998) ERS task force report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 11(4):986\u2013991","journal-title":"Eur Respir J"},{"issue":"5","key":"3748_CR4","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1183\/09031936.01.17510340","volume":"17","author":"E Bouza","year":"2001","unstructured":"Members of the Task Force, Bouza E, Brun-Buisson C, Chastre J et al (2001) Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet. Eur Respir J 17(5):1034\u20131045","journal-title":"Eur Respir J"},{"issue":"1","key":"3748_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00134-008-1336-9","volume":"35","author":"A Torres","year":"2009","unstructured":"Torres A, Ewig S, Lode H, Carlet J (2009) For the European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 35(1):9\u201329","journal-title":"Intensive Care Med"},{"issue":"7454","key":"3748_CR6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490","journal-title":"BMJ"},{"issue":"7651","key":"3748_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch\u00fcnemann HJ et al (2008) What is \u2018quality of evidence\u2019 and why is it important to clinicians? BMJ 336(7651):995\u2013998","journal-title":"BMJ"},{"issue":"17","key":"3748_CR8","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1001\/jama.1992.03490170092032","volume":"268","author":"Evidence-Based Medicine Working Group","year":"1992","unstructured":"Evidence-Based Medicine Working Group (1992) Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268(17):2420\u20132425","journal-title":"JAMA"},{"issue":"11","key":"3748_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jama.2019.1122","volume":"321","author":"AC Fanaroff","year":"2019","unstructured":"Fanaroff AC, Califf RM, Windecker S, Smith SC, Lopes RD (2019) Levels of evidence supporting American College of Cardiology\/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA 321(11):1069\u20131080","journal-title":"JAMA"},{"key":"3748_CR10","doi-asserted-by":"crossref","unstructured":"Schumacher RC, Nguyen OK, Desphande K, Makam AN (2019) Evidence-based medicine and the American Thoracic Society clinical practice guidelines. JAMA Intern Med","DOI":"10.1001\/jamainternmed.2018.7461"},{"issue":"10","key":"3748_CR11","doi-asserted-by":"publisher","first-page":"e0204720","DOI":"10.1371\/journal.pone.0204720","volume":"13","author":"C Meyer","year":"2018","unstructured":"Meyer C, Bowers A, Wayant C, Checketts J, Scott J, Musuvathy S, Vassar M (2018) Scientific evidence underlying the American College of Gastroenterology\u2019s clinical practice guidelines. PLoS One 13(10):e0204720","journal-title":"PLoS One"},{"issue":"6","key":"3748_CR12","doi-asserted-by":"publisher","first-page":"e0178456","DOI":"10.1371\/journal.pone.0178456","volume":"12","author":"AK Venkatesh","year":"2017","unstructured":"Venkatesh AK, Savage D, Sandefur B, Bernard KR, Rothenberg C, Schuur JD (2017) Systematic review of emergency medicine clinical practice guidelines: implications for research and policy. PLoS One 12(6):e0178456","journal-title":"PLoS One"},{"issue":"3","key":"3748_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ajkd.2015.09.016","volume":"67","author":"M Alseiari","year":"2016","unstructured":"Alseiari M, Meyer KB, Wong JB (2016) Evidence underlying KDIGO (kidney disease: improving global outcomes) guideline recommendations: a systematic review. Am J Kidney Dis Off J Natl Kidney Found 67(3):417\u2013422","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"6","key":"3748_CR14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/hep.26578","volume":"58","author":"C Koh","year":"2013","unstructured":"Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA (2013) AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatol Baltim Md 58(6):2142\u20132152","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"3748_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2010.31.6414","volume":"29","author":"TK Poonacha","year":"2011","unstructured":"Poonacha TK, Go RS (2011) Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol Off J Am Soc Clin Oncol 29(2):186\u2013191","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"3748_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1086\/656735","volume":"51","author":"AR Khan","year":"2010","unstructured":"Khan AR, Khan S, Zimmerman V, Baddour LM, Tleyjeh IM (2010) Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis Off Publ Infect Dis Soc Am 51(10):1147\u20131156","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"3748_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/archinternmed.2010.482","volume":"171","author":"DH Lee","year":"2011","unstructured":"Lee DH, Vielemeyer O (2011) Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 171(1):18\u201322","journal-title":"Arch Intern Med"},{"key":"3748_CR18","doi-asserted-by":"crossref","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H et al (2017) International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur Respir J 50(3)","DOI":"10.1183\/13993003.00582-2017"},{"key":"3748_CR19","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB et al (2016) Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis Off Publ Infect Dis Soc Am 63(5):e61\u2013e111"},{"issue":"8","key":"3748_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/677144","volume":"35","author":"M Klompas","year":"2014","unstructured":"Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G et al (2014) Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(8):915\u2013936","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3748_CR21","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 339:b2700","journal-title":"BMJ."},{"key":"3748_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2334-14-211","volume":"14","author":"B Borgatta","year":"2014","unstructured":"Borgatta B, Rello J (2014) How to approach and treat VAP in ICU patients. BMC Infect Dis 14:211","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3748_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1378\/chest.111.3.676","volume":"111","author":"CM Luna","year":"1997","unstructured":"Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 111(3):676\u2013685","journal-title":"Chest."},{"issue":"9","key":"3748_CR24","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","volume":"38","author":"A Kumar","year":"2010","unstructured":"Kumar A, Zarychanski R, Light B, Parrillo J, Maki D, Simon D et al (2010) Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 38(9):1773\u20131785","journal-title":"Crit Care Med"},{"issue":"1","key":"3748_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcrc.2007.08.007","volume":"23","author":"EL Kuti","year":"2008","unstructured":"Kuti EL, Patel AA, Coleman CI (2008) Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care 23(1):91\u2013100","journal-title":"J Crit Care"},{"issue":"3","key":"3748_CR26","doi-asserted-by":"publisher","first-page":"322.e7","DOI":"10.1016\/j.jcrc.2011.09.004","volume":"27","author":"JG Muscedere","year":"2012","unstructured":"Muscedere JG, Shorr AF, Jiang X, Day A, Heyland DK, Canadian Critical Care Trials Group (2012) The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. J Crit Care 27(3):322.e7\u2013322.14","journal-title":"J Crit Care"},{"issue":"6","key":"3748_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1183\/09031936.00093010","volume":"37","author":"J Rello","year":"2011","unstructured":"Rello J, Ulldemolins M, Lisboa T, Koulenti D, Ma\u00f1ez R, Martin-Loeches I et al (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37(6):1332\u20131339","journal-title":"Eur Respir J"},{"issue":"1","key":"3748_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mayocp.2013.09.013","volume":"89","author":"JD Feuerstein","year":"2014","unstructured":"Feuerstein JD, Akbari M, Gifford AE, Hurley CM, Leffler DA, Sheth SG et al (2014) Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines. Mayo Clin Proc 89(1):16\u201324","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3748_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1183\/09031936.00048507","volume":"30","author":"L Lorente","year":"2007","unstructured":"Lorente L, Blot S, Rello J (2007) Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 30(6):1193\u20131207","journal-title":"Eur Respir J"},{"key":"3748_CR30","doi-asserted-by":"crossref","unstructured":"Alhazzani W, M\u00f8ller MH, Belley-Cote E, Citerio G (2019) Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future. Intensive Care Med","DOI":"10.1007\/s00134-019-05786-9"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03748-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:26:27Z","timestamp":1607477187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03748-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3748"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03748-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"12 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JR served on speakers\u2019 bureau and consultant for Pfizer and Astellas.MIR served as co-author in redacting IDSA\/ATS guidelines on HAP\/VAP (2016).The remaining authors, LC, ST, JFC, declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}